Abiopharma

Janux - Investor Relations - Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors

Vivani Subsidiary Cortigent to Present OrionSystem’s Advanced Brain Implant Technology in Poster Session at NANS 2026

ProPhase Labs Uplists from Pink Sheets to OTC Market

Cypherpunk Adds Arjun Khemani as Strategic Advisor

SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer

Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01

Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock